HAS Healthcare and Cerbios-Pharma Merge to Revolutionize the CDMO Sector with Strong Backing A landmark acquisition between HAS Healthcare and Cerbios-Pharma aims to reshape the CDMO landscape in Ticino, boosting growth and innovation in pharmaceuticals.

HAS Healthcare and Cerbios-Pharma Merge to Revolutionize the CDMO Sector with Strong Backing #Switzerland #Cerbios-Pharma #HAS_Healthcare #Biasca #CDMO_sector

HAS Healthcare Advanced Synthesis and Cerbios-Pharma Join Forces to Lead the CDMO Sector HAS Healthcare Advanced Synthesis has acquired Cerbios-Pharma to form a powerhouse in the CDMO sector, enhancing capabilities and market reach.

HAS Healthcare Advanced Synthesis and Cerbios-Pharma Join Forces to Lead the CDMO Sector #Switzerland #Cerbios-Pharma #HAS_Healthcare #Biasca #CDMO_sector

HAS Healthcare Advanced Synthesis Acquires Cerbios-Pharma to Forge a Leading International CDMO Group HAS Healthcare has announced its acquisition of Cerbios-Pharma, aiming to create a powerful global player in the CDMO sector with support from 65 Equity Partners.

HAS Healthcare Advanced Synthesis Acquires Cerbios-Pharma to Forge a Leading International CDMO Group #Switzerland #Cerbios-Pharma #HAS_Healthcare #65_Equity_Partners #Biasca

HAS Healthcare Advanced Synthesis SA Acquires Cerbios-Pharma SA to Create a Global CDMO Leader HAS Healthcare Advanced Synthesis SA's acquisition of Cerbios-Pharma SA, supported by 65 Equity Partners, aims to establish a leading global CDMO entity for better pharmaceutical solutions.

HAS Healthcare Advanced Synthesis SA Acquires Cerbios-Pharma SA to Create a Global CDMO Leader #Switzerland #Cerbios-Pharma #HAS_Healthcare #65_Equity_Partners #Biasca

HAS Healthcare and Cerbios-Pharma Join Forces to Lead the CDMO Sector Internationally HAS Healthcare Advanced Synthesis SA has successfully acquired Cerbios-Pharma SA, establishing a formidable international CDMO group backed by 65 Equity Partners.

HAS Healthcare and Cerbios-Pharma Join Forces to Lead the CDMO Sector Internationally #Switzerland #Cerbios-Pharma #HAS_Healthcare #65_Equity_Partners #Biasca